Fig. 4. Inhibition of LNCaP cell proliferation.
(A) LNCaP cells were treated with 1 and 10 μM of AT-1, SD-2163, SD-2164, SD-2406, and SD-2407 for 72 h. Cell images were captured using a live cell imaging system. (B) Cell viability of BRD4 PROTAC-treated LNCaP cells. Results are presented as the mean ± S.D. *P<0.05, **P<0.01 vs CTR.